Altogether, these findings demonstrated that the chaperoning of SRC kinase by HSP90 contributed to the proliferation and growth of T-ALL and B-ALL cells, which provides novel targeting strategies for ALL treatment. Here, HSP90AA1 is linked to acute lymphoblastic leukemia.